| - GRCh37:
- Chr1:53061024-77233450
- GRCh38:
- Chr1:52595352-76767765
| ACADM, ACOT11, AK4, ALG6, ANGPTL3, ANKRD13C, ASB17, ATG4C, BSND, C1orf141, C1orf87, C8A, C8B, CACHD1, CDCP2, COA7, CPT2, CRYZ, CTH, CYB5RL, CYP2J2, CZIB, DAB1, DAB1-AS1, DEPDC1, DEPDC1-AS1, DHCR24, DIO1, DIRAS3, DLEU2L, DMRTB1, DNAI4, DNAJC6, DOCK7, DYNLT5, ECHDC2, EFCAB7, ERICH3, ERICH3-AS1, FAM151A, FGGY, FOXD3, FOXD3-AS1, FPGT, FPGT-TNNI3K, FYB2, GADD45A, GLIS1, GNG12, GNG12-AS1, GPX7, HHLA3, HHLA3-AS1, HOOK1, HSD52, IFT25, IL12RB2, IL23R, INSL5, ITGB3BP, JAK1, JUN, KANK4, L1TD1, LDLRAD1, LEPR, LEPROT, LEXM, LHX8, LINC00466, LINC01135, LINC01358, LINC01359, LINC01360, LINC01707, LINC01739, LINC01748, LINC01753, LINC01755, LINC01758, LINC01767, LINC01788, LINC02238, LINC02567, LINC02777, LINC02784, LINC02791, LINC02796, LOC100507634, LOC101926944, LOC101926964, LOC101927342, LOC101929935, LOC107983962, LOC110120599, LOC110120600, LOC110120659, LOC110120763, LOC110121050, LOC110121108, LOC110121124, LOC110121125, LOC110121126, LOC110121161, LOC111501769, LOC112590804, LOC112590805, LOC112590806, LOC112590807, LOC112590808, LOC112590809, LOC112590810, LOC112590812, LOC112590814, LOC112590815, LOC112590816, LOC112590817, LOC112590818, LOC112590819, LOC112590820, LOC114827846, LOC115801429, LOC115801430, LOC120893134, LOC120893135, LOC120893136, LOC120893137, LOC120893138, LOC120893139, LOC120893140, LOC120893141, LOC121725023, LOC121725024, LOC121725025, LOC121725026, LOC121725027, LOC121725028, LOC121725029, LOC121725030, LOC121725032, LOC121725033, LOC122056873, LOC122056874, LOC122056875, LOC122056876, LOC122056877, LOC122056878, LOC122056879, LOC122056880, LOC122056881, LOC122056882, LOC122056883, LOC122056884, LOC122056887, LOC122056888, LOC122056889, LOC122056890, LOC122056891, LOC122056892, LOC122056893, LOC122056894, LOC122056895, LOC122056896, LOC122056897, LOC122056898, LOC122094839, LOC122094840, LOC122094841, LOC122094842, LOC122094843, LOC122094844, LOC122094845, LOC122094846, LOC122094847, LOC122094848, LOC122094849, LOC122094850, LOC122094851, LOC122094853, LOC126805734, LOC126805735, LOC126805736, LOC126805737, LOC126805738, LOC126805739, LOC126805740, LOC126805741, LOC126805742, LOC126805743, LOC126805744, LOC126805745, LOC126805746, LOC126805747, LOC126805748, LOC126805749, LOC126805750, LOC126805751, LOC126805752, LOC126805753, LOC126805754, LOC126805755, LOC126805756, LOC126805757, LOC126805758, LOC126805759, LOC126805760, LOC126805761, LOC126805762, LOC128772198, LRP8, LRP8-DT, LRRC40, LRRC42, LRRC53, LRRC7, LRRC7-AS1, LRRIQ3, MAGOH, MAGOH-DT, MIER1, MIR101-1, MIR12132, MIR1262, MIR1273F, MIR1273G, MIR186, MIR3116-1, MIR3116-2, MIR3117, MIR3671, MIR4422, MIR4422HG, MIR4711, MIR4781, MIR4794, MIR5095, MIR6068, MROH7, MROH7-TTC4, MRPL37, MSH4, MYSM1, NDC1, NEGR1, NEGR1-IT1, NFIA, NFIA-AS1, NFIA-AS2, OMA1, PARS2, PATJ, PCSK9, PDE4B, PDE4B-AS1, PGM1, PLPP3, PODN, PRKAA2, PTGER3, RABGGTB, RAVER2, ROR1, ROR1-AS1, RPE65, SCP2, SERBP1, SGIP1, SHISAL2A, SLC1A7, SLC35D1, SLC44A5, SNORD45A, SNORD45B, SNORD45C, SRSF11, SSBP3, SSBP3-AS1, ST6GALNAC3, TACSTD2, TCEANC2, TM2D1, TMEM59, TMEM61, TNNI3K, TRK-CTT7-1, TTC22, TTC4, TYW3, UBE2U, USP1, USP24, WLS, YIPF1, ZRANB2, ZRANB2-AS1, ZRANB2-DT, ZYG11A, ZYG11B | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr1:53253175-67805556
- GRCh38:
- Chr1:52787503-67339873
| LRP8-DT, LRRC42, MAGOH, MAGOH-DT, MIER1, MIR101-1, MIR12132, MIR1273F, MIR1273G, MIR3116-1, MIR3116-2, MIR3117, MIR3671, MIR4422, MIR4422HG, MIR4711, MIR4781, MIR4794, MIR5095, MIR6068, MROH7, MROH7-TTC4, MRPL37, MYSM1, NDC1, NFIA, NFIA-AS1, NFIA-AS2, OMA1, PARS2, PATJ, PCSK9, PDE4B, PDE4B-AS1, PGM1, PLPP3, PODN, PRKAA2, RAVER2, ROR1, ROR1-AS1, SCP2, SGIP1, SLC1A7, SLC35D1, SSBP3, SSBP3-AS1, TACSTD2, TCEANC2, TM2D1, TMEM59, TMEM61, TRK-CTT7-1, TTC22, TTC4, UBE2U, USP1, USP24, YIPF1, ZYG11A, ZYG11B, ACOT11, AK4, ALG6, ANGPTL3, ATG4C, BSND, C1orf141, C1orf87, C8A, C8B, CACHD1, CDCP2, CPT2, CYB5RL, CYP2J2, CZIB, DAB1, DAB1-AS1, DHCR24, DIO1, DLEU2L, DMRTB1, DNAI4, DNAJC6, DOCK7, DYNLT5, ECHDC2, EFCAB7, FAM151A, FGGY, FOXD3, FOXD3-AS1, FYB2, GLIS1, HOOK1, HSD52, IFT25, IL12RB2, IL23R, INSL5, ITGB3BP, JAK1, JUN, KANK4, L1TD1, LDLRAD1, LEPR, LEPROT, LEXM, LINC00466, LINC01135, LINC01358, LINC01359, LINC01739, LINC01748, LINC01753, LINC01755, LINC01767, LINC02777, LINC02784, LOC100507634, LOC101926944, LOC101926964, LOC101929935, LOC107983962, LOC110120599, LOC110120600, LOC110120659, LOC110120763, LOC110121050, LOC110121108, LOC110121124, LOC110121125, LOC110121126, LOC110121161, LOC111501769, LOC112590805, LOC112590806, LOC112590807, LOC112590808, LOC112590809, LOC112590810, LOC112590812, LOC112590814, LOC112590815, LOC112590816, LOC112590817, LOC112590818, LOC114827846, LOC120893134, LOC120893135, LOC120893136, LOC120893137, LOC120893138, LOC120893139, LOC120893140, LOC121725023, LOC121725024, LOC121725025, LOC121725026, LOC121725027, LOC121725028, LOC122056875, LOC122056876, LOC122056877, LOC122056878, LOC122056879, LOC122056880, LOC122056881, LOC122056882, LOC122056883, LOC122056884, LOC122056887, LOC122056888, LOC122056889, LOC122056890, LOC122056891, LOC122056892, LOC122056893, LOC122056894, LOC122056895, LOC122056896, LOC122056897, LOC122056898, LOC122094839, LOC122094840, LOC122094841, LOC122094842, LOC122094843, LOC122094844, LOC122094845, LOC126805734, LOC126805735, LOC126805736, LOC126805737, LOC126805738, LOC126805739, LOC126805740, LOC126805741, LOC126805742, LOC126805743, LOC126805744, LOC126805745, LOC126805746, LOC126805747, LOC126805748, LOC126805749, LOC126805750, LOC128772198, LRP8 | | See cases | Likely pathogenic (May 7, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr1:54092945-64714537
- GRCh38:
- Chr1:53627272-64248854
| ROR1, ROR1-AS1, SSBP3, SSBP3-AS1, TACSTD2, TCEANC2, TM2D1, TMEM59, TMEM61, TRK-CTT7-1, TTC22, TTC4, UBE2U, USP1, USP24, YIPF1, ACOT11, ALG6, ANGPTL3, ATG4C, BSND, C1orf87, C8A, C8B, CDCP2, CYB5RL, CYP2J2, DAB1, DAB1-AS1, DHCR24, DIO1, DLEU2L, DOCK7, EFCAB7, FAM151A, FGGY, FOXD3, FOXD3-AS1, FYB2, GLIS1, HOOK1, HSD52, IFT25, ITGB3BP, JUN, KANK4, L1TD1, LDLRAD1, LEXM, LINC00466, LINC01135, LINC01358, LINC01739, LINC01748, LINC01753, LINC01755, LINC01767, LINC02777, LINC02784, LOC100507634, LOC101926944, LOC101926964, LOC101929935, LOC110120599, LOC110120600, LOC110120659, LOC110120763, LOC110121050, LOC110121108, LOC110121124, LOC110121125, LOC110121126, LOC110121161, LOC111501769, LOC112590806, LOC112590807, LOC112590808, LOC112590809, LOC112590810, LOC112590812, LOC112590814, LOC112590815, LOC120893136, LOC120893137, LOC120893138, LOC120893139, LOC120893140, LOC121725023, LOC121725024, LOC121725025, LOC121725026, LOC121725027, LOC121725028, LOC122056878, LOC122056879, LOC122056880, LOC122056881, LOC122056882, LOC122056883, LOC122056884, LOC122056887, LOC122056888, LOC122056889, LOC122056890, LOC122056891, LOC122056892, LOC122056893, LOC122056894, LOC122056895, LOC122056896, LOC122056897, LOC122056898, LOC122094839, LOC122094840, LOC122094841, LOC122094842, LOC126805734, LOC126805735, LOC126805736, LOC126805737, LOC126805738, LOC126805739, LOC126805740, LOC126805741, LOC126805742, LOC126805743, LOC126805744, LOC126805745, LOC126805746, LOC128772198, LRRC42, MIR12132, MIR3116-1, MIR3116-2, MIR4422, MIR4422HG, MIR4711, MIR4781, MIR6068, MROH7, MROH7-TTC4, MRPL37, MYSM1, NDC1, NFIA, NFIA-AS1, NFIA-AS2, OMA1, PARS2, PATJ, PCSK9, PGM1, PLPP3, PRKAA2 | | See cases | Pathogenic (Jul 5, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr1:54203885-61905320
- GRCh38:
- Chr1:53738212-61439648
| ACOT11, BSND, C1orf87, C8A, C8B, CDCP2, CYB5RL, CYP2J2, DAB1, DAB1-AS1, DHCR24, DIO1, FAM151A, FGGY, FYB2, GLIS1, HOOK1, HSD52, IFT25, JUN, LDLRAD1, LEXM, LINC01135, LINC01358, LINC01748, LINC01753, LINC01755, LINC01767, LINC02777, LINC02784, LOC100507634, LOC101926944, LOC101926964, LOC101929935, LOC110121125, LOC110121126, LOC110121161, LOC111501769, LOC112590806, LOC112590807, LOC112590808, LOC112590809, LOC112590810, LOC112590812, LOC112590814, LOC120893136, LOC120893137, LOC120893138, LOC120893139, LOC120893140, LOC121725023, LOC121725024, LOC121725025, LOC122056879, LOC122056880, LOC122056881, LOC122056882, LOC122056883, LOC122056884, LOC122056887, LOC122056888, LOC122056889, LOC122056890, LOC122056891, LOC122056892, LOC122056893, LOC122056894, LOC122056895, LOC122056896, LOC122056897, LOC126805734, LOC126805735, LOC126805736, LOC126805737, LOC126805738, LOC126805739, LOC126805740, LOC126805741, LOC126805742, LOC126805743, LRRC42, MIR4422, MIR4422HG, MIR4711, MIR4781, MROH7, MROH7-TTC4, MRPL37, MYSM1, NDC1, NFIA, NFIA-AS1, NFIA-AS2, OMA1, PARS2, PCSK9, PLPP3, PRKAA2, SSBP3, SSBP3-AS1, TACSTD2, TCEANC2, TMEM59, TMEM61, TRK-CTT7-1, TTC22, TTC4, USP24, YIPF1 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55496039
- GRCh38:
- Chr1:55030366
| PCSK9 | | Familial hypercholesterolemia | association (Mar 3, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr1:55504650
- GRCh38:
- Chr1:55038977
| PCSK9 | | Hypercholesterolemia, familial, 1 | Benign (Aug 23, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505158
- GRCh38:
- Chr1:55039485
| PCSK9 | | Hypercholesterolemia, familial, 1, Familial hypobetalipoproteinemia | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505165
- GRCh38:
- Chr1:55039492
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Hypobetalipoproteinemia | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505180
- GRCh38:
- Chr1:55039507
| PCSK9 | | Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, 3, Hypobetalipoproteinemia, not provided | Uncertain significance (Jan 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505224
- GRCh38:
- Chr1:55039551
| PCSK9 | | Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, 3, Hypobetalipoproteinemia
| Benign/Likely benign (Jan 12, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505266
- GRCh38:
- Chr1:55039593
| PCSK9 | | Hypobetalipoproteinemia, Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Aug 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505266
- GRCh38:
- Chr1:55039593
| PCSK9 | | Hypobetalipoproteinemia, Hypercholesterolemia, autosomal dominant, 3, Hypercholesterolemia, familial, 1
| Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505274
- GRCh38:
- Chr1:55039601
| PCSK9 | | Familial hypobetalipoproteinemia, Hypercholesterolemia, familial, 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505290
- GRCh38:
- Chr1:55039617
| PCSK9 | | Hypercholesterolemia, familial, 1, Familial hypobetalipoproteinemia | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505311
- GRCh38:
- Chr1:55039638
| PCSK9 | | Hypercholesterolemia, familial, 1, Familial hypobetalipoproteinemia | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505326
- GRCh38:
- Chr1:55039653
| PCSK9 | | Hypercholesterolemia, familial, 1, Familial hypobetalipoproteinemia | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505331
- GRCh38:
- Chr1:55039658
| PCSK9 | | Hypercholesterolemia, familial, 1, Familial hypobetalipoproteinemia | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505343
- GRCh38:
- Chr1:55039670
| PCSK9 | | Hypercholesterolemia, familial, 1 | Benign | no assertion criteria provided |
| - GRCh37:
- Chr1:55505371
- GRCh38:
- Chr1:55039698
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Hypobetalipoproteinemia | Conflicting interpretations of pathogenicity (Apr 28, 2017) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505438
- GRCh38:
- Chr1:55039765
| PCSK9 | | Hypercholesterolemia, familial, 1 | Uncertain significance (Mar 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505443
- GRCh38:
- Chr1:55039770
| PCSK9 | | Hypobetalipoproteinemia, Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505444
- GRCh38:
- Chr1:55039771
| PCSK9 | | Hypercholesterolemia, familial, 1 | Uncertain significance (Mar 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505447
- GRCh38:
- Chr1:55039774
| PCSK9 | | Hypobetalipoproteinemia, Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, 3
| Benign (Jan 13, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505485
- GRCh38:
- Chr1:55039812
| PCSK9 | | Hypobetalipoproteinemia, Hypercholesterolemia, autosomal dominant, 3 | Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505502
- GRCh38:
- Chr1:55039829
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Mar 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505503
- GRCh38:
- Chr1:55039830
| PCSK9 | | Familial hypercholesterolemia, Hypercholesterolemia, familial, 1 | Conflicting interpretations of pathogenicity (Mar 23, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505512
- GRCh38:
- Chr1:55039839
| PCSK9 | M1R | Familial hypercholesterolemia | Uncertain significance (Jun 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505516
- GRCh38:
- Chr1:55039843
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Apr 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505518
- GRCh38:
- Chr1:55039845
| PCSK9 | T3N | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505519
- GRCh38:
- Chr1:55039846
| PCSK9 | | Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jul 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505520
- GRCh38:
- Chr1:55039847
| PCSK9 | V4L | Familial hypercholesterolemia | Uncertain significance (Dec 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505520
- GRCh38:
- Chr1:55039847
| PCSK9 | V4I | Cardiovascular phenotype, Familial hypercholesterolemia, Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, 3 | Conflicting interpretations of pathogenicity (Oct 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505527
- GRCh38:
- Chr1:55039854
| PCSK9 | S6F | Familial hypercholesterolemia | Uncertain significance (Nov 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505531
- GRCh38:
- Chr1:55039858
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Nov 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505532
- GRCh38:
- Chr1:55039859
| PCSK9 | R8W | Familial hypercholesterolemia | Uncertain significance (Jul 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505537
- GRCh38:
- Chr1:55039864
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype | Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505537
- GRCh38:
- Chr1:55039864
| PCSK9 | | Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Dec 11, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505544
- GRCh38:
- Chr1:55039871
| PCSK9 | P12T | Familial hypercholesterolemia, Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3
| Uncertain significance (Sep 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505545
- GRCh38:
- Chr1:55039872
| PCSK9 | P12L | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Conflicting interpretations of pathogenicity (Sep 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505546
- GRCh38:
- Chr1:55039873
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Jul 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505550
- GRCh38:
- Chr1:55039877
| PCSK9 | P14S | Familial hypercholesterolemia | Uncertain significance (Nov 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505552
- GRCh38:
- Chr1:55039879
| PCSK9 | | Cardiovascular phenotype | Likely benign (Mar 7, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505552-55505554
- GRCh38:
- Chr1:55039879-55039881
| PCSK9 | L23del | Familial hypercholesterolemia | Likely benign (Mar 19, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505552-55505560
- GRCh38:
- Chr1:55039879-55039887
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Conflicting interpretations of pathogenicity (Aug 26, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505552-55505553
- GRCh38:
- Chr1:55039879-55039880
| PCSK9 | | Familial hypercholesterolemia, not provided, Hypercholesterolemia, autosomal dominant, 3
| Uncertain significance (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505552-55505553
- GRCh38:
- Chr1:55039879-55039880
| PCSK9 | | Cardiovascular phenotype, Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3, not specified, not provided | Conflicting interpretations of pathogenicity (Oct 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505552-55505553
- GRCh38:
- Chr1:55039879-55039880
| PCSK9 | L15fs | Hypercholesterolemia, familial, 1 | Pathogenic (Mar 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505552-55505553
- GRCh38:
- Chr1:55039879-55039880
| PCSK9 | | not provided, Hypercholesterolemia, autosomal dominant, 3, Hypercholesterolemia, familial, 1, not specified, Cardiovascular phenotype, Familial hypercholesterolemia
| Conflicting interpretations of pathogenicity (Mar 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505552-55505553
- GRCh38:
- Chr1:55039879-55039880
| PCSK9 | | Familial hypercholesterolemia, Hypercholesterolemia, familial, 1, Cardiovascular phenotype, not specified, Hypercholesterolemia, autosomal dominant, 3, not provided
| Benign/Likely benign (Nov 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505553-55505561
- GRCh38:
- Chr1:55039880-55039888
| PCSK9 | | Familial hypercholesterolemia | Uncertain significance (Nov 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505553-55505554
- GRCh38:
- Chr1:55039880-55039881
| PCSK9 | | Familial hypercholesterolemia | Uncertain significance (Sep 24, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505553-55505558
- GRCh38:
- Chr1:55039880-55039885
| PCSK9 | | Familial hypercholesterolemia, Cardiovascular phenotype | Likely benign (Jun 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505553-55505555
- GRCh38:
- Chr1:55039880-55039882
| PCSK9 | L23del | not specified, not provided, Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype | Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505560-55505561
- GRCh38:
- Chr1:55039887-55039888
| PCSK9 | | not provided | Likely benign (Sep 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505562
- GRCh38:
- Chr1:55039889
| PCSK9 | | Cardiovascular phenotype | Likely benign (Jul 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505567
- GRCh38:
- Chr1:55039894
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Feb 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505573-55505574
- GRCh38:
- Chr1:55039900-55039901
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505575-55505576
- GRCh38:
- Chr1:55039902-55039903
| PCSK9 | | Familial hypercholesterolemia | Uncertain significance (Nov 10, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:55505575
- GRCh38:
- Chr1:55039902
| PCSK9 | L22P | Familial hypercholesterolemia | Uncertain significance (Nov 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505576
- GRCh38:
- Chr1:55039903
| PCSK9 | | Cardiovascular phenotype, Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3
| Likely benign (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505580
- GRCh38:
- Chr1:55039907
| PCSK9 | G24S | Cardiovascular phenotype, Familial hypercholesterolemia | Uncertain significance (Nov 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505586
- GRCh38:
- Chr1:55039913
| PCSK9 | A26T | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr1:55505587
- GRCh38:
- Chr1:55039914
| PCSK9 | A26V | Familial hypercholesterolemia, Cardiovascular phenotype | Uncertain significance (Feb 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505588
- GRCh38:
- Chr1:55039915
| PCSK9 | | Cardiovascular phenotype | Likely benign (Nov 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505590
- GRCh38:
- Chr1:55039917
| PCSK9 | G27D | Cardiovascular phenotype | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505590
- GRCh38:
- Chr1:55039917
| PCSK9 | G27A | Familial hypercholesterolemia | Uncertain significance (Apr 29, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505591
- GRCh38:
- Chr1:55039918
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Jul 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505593
- GRCh38:
- Chr1:55039920
| PCSK9 | R29fs | Hypercholesterolemia, familial, 1, not specified | Conflicting interpretations of pathogenicity (Sep 29, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505594
- GRCh38:
- Chr1:55039921
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Feb 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505595
- GRCh38:
- Chr1:55039922
| PCSK9 | R29C | Familial hypercholesterolemia | Uncertain significance (Feb 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505595
- GRCh38:
- Chr1:55039922
| PCSK9 | R29G | Hypobetalipoproteinemia, Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505596
- GRCh38:
- Chr1:55039923
| PCSK9 | R29H | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505599
- GRCh38:
- Chr1:55039926
| PCSK9 | A30E | Familial hypercholesterolemia | Uncertain significance (Dec 5, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505600
- GRCh38:
- Chr1:55039927
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Nov 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505603-55505604
- GRCh38:
- Chr1:55039930-55039931
| PCSK9 | | Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505604
- GRCh38:
- Chr1:55039931
| PCSK9 | E32K | Hypobetalipoproteinemia, Homozygous familial hypercholesterolemia, Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype, not provided, Hypercholesterolemia, familial, 1 | Conflicting interpretations of pathogenicity (Apr 7, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505606
- GRCh38:
- Chr1:55039933
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505607
- GRCh38:
- Chr1:55039934
| PCSK9 | D33N | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Uncertain significance (Feb 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505610
- GRCh38:
- Chr1:55039937
| PCSK9 | E34K | Cardiovascular phenotype, Familial hypercholesterolemia, not specified, Hypercholesterolemia, autosomal dominant, 3, Hypobetalipoproteinemia | Uncertain significance (Mar 27, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505613
- GRCh38:
- Chr1:55039940
| PCSK9 | D35Y | Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype, Familial hypercholesterolemia
| Conflicting interpretations of pathogenicity (Jul 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505615
- GRCh38:
- Chr1:55039942
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Oct 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505616
- GRCh38:
- Chr1:55039943
| PCSK9 | G36S | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Uncertain significance (Apr 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505617
- GRCh38:
- Chr1:55039944
| PCSK9 | G36D | Cardiovascular phenotype | Uncertain significance (Dec 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505618
- GRCh38:
- Chr1:55039945
| PCSK9 | | Cardiovascular phenotype | Likely benign (Nov 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505618
- GRCh38:
- Chr1:55039945
| PCSK9 | | Cardiovascular phenotype | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505621
- GRCh38:
- Chr1:55039948
| PCSK9 | D37E | Cardiovascular phenotype | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505624
- GRCh38:
- Chr1:55039951
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505625
- GRCh38:
- Chr1:55039952
| PCSK9 | E39K | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505628
- GRCh38:
- Chr1:55039955
| PCSK9 | E40K | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505633
- GRCh38:
- Chr1:55039960
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Feb 25, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505636
- GRCh38:
- Chr1:55039963
| PCSK9 | | Cardiovascular phenotype, Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3
| Likely benign (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505642
- GRCh38:
- Chr1:55039969
| PCSK9 | | Familial hypercholesterolemia | Likely benign (Aug 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505645
- GRCh38:
- Chr1:55039972
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505646
- GRCh38:
- Chr1:55039973
| PCSK9 | R46C | Familial hypercholesterolemia | Uncertain significance (Oct 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505647
- GRCh38:
- Chr1:55039974
| PCSK9 | R46L | Cardiovascular phenotype, Hypobetalipoproteinemia, Familial hypercholesterolemia, not provided, not specified, Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, 3 | Benign/Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505648
- GRCh38:
- Chr1:55039975
| PCSK9 | | Cardiovascular phenotype | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505650
- GRCh38:
- Chr1:55039977
| PCSK9 | S47C | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr1:55505651
- GRCh38:
- Chr1:55039978
| PCSK9 | | Cardiovascular phenotype, Hypobetalipoproteinemia, not provided, not specified, Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, 3
| Conflicting interpretations of pathogenicity (Mar 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55505652
- GRCh38:
- Chr1:55039979
| PCSK9 | E48* | Familial hypercholesterolemia | Likely benign (Sep 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505652
- GRCh38:
- Chr1:55039979
| PCSK9 | E48K | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |